New-onset heart failure: free-breathing motion-corrected late gadolinium enhancement rescues the endomyocardial fibrosis diagnosis

Eur Heart J. 2019 Dec 21;40(48):3951. doi: 10.1093/eurheartj/ehz672.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Angiography / methods
  • Atrial Natriuretic Factor / blood
  • Contrast Media / administration & dosage
  • Echocardiography / methods
  • Electrocardiography / methods
  • Endomyocardial Fibrosis / complications
  • Endomyocardial Fibrosis / diagnostic imaging*
  • Endomyocardial Fibrosis / pathology
  • Female
  • Gadolinium / administration & dosage
  • Heart Failure / diagnosis*
  • Heart Failure / etiology
  • Heart Failure / therapy
  • Humans
  • Hypereosinophilic Syndrome / diagnostic imaging
  • Hypereosinophilic Syndrome / pathology
  • Magnetic Resonance Spectroscopy / methods
  • Prognosis
  • Protein Precursors / blood
  • Respiration
  • Stroke Volume / physiology
  • Tachycardia, Supraventricular / diagnosis*
  • Tachycardia, Supraventricular / etiology
  • Ventricular Dysfunction, Left / diagnostic imaging
  • Ventricular Dysfunction, Left / physiopathology

Substances

  • Contrast Media
  • N-terminal proatrial natriuretic peptide
  • Protein Precursors
  • Atrial Natriuretic Factor
  • Gadolinium